These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 29405696

  • 41. Targeting of arenavirus RNA synthesis by a carboxamide-derivatized aromatic disulfide with virucidal activity.
    Sepúlveda CS, García CC, Levingston Macleod JM, López N, Damonte EB.
    PLoS One; 2013; 8(11):e81251. PubMed ID: 24278404
    [Abstract] [Full Text] [Related]

  • 42. A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.
    Ziegler CM, Eisenhauer P, Kelly JA, Dang LN, Beganovic V, Bruce EA, King BR, Shirley DJ, Weir ME, Ballif BA, Botten J.
    J Virol; 2018 Feb 15; 92(4):. PubMed ID: 29187543
    [Abstract] [Full Text] [Related]

  • 43. A Map of the Arenavirus Nucleoprotein-Host Protein Interactome Reveals that Junín Virus Selectively Impairs the Antiviral Activity of Double-Stranded RNA-Activated Protein Kinase (PKR).
    King BR, Hershkowitz D, Eisenhauer PL, Weir ME, Ziegler CM, Russo J, Bruce EA, Ballif BA, Botten J.
    J Virol; 2017 Aug 01; 91(15):. PubMed ID: 28539447
    [Abstract] [Full Text] [Related]

  • 44. Current drug discovery strategies against arenavirus infections.
    Pasquato A, Burri DJ, Kunz S.
    Expert Rev Anti Infect Ther; 2012 Nov 01; 10(11):1297-309. PubMed ID: 23241187
    [Abstract] [Full Text] [Related]

  • 45. Mammarenaviral Infection Is Dependent on Directional Exposure to and Release from Polarized Intestinal Epithelia.
    Warner NL, Jokinen JD, Beier JI, Sokoloski KJ, Lukashevich IS.
    Viruses; 2018 Feb 10; 10(2):. PubMed ID: 29439402
    [Abstract] [Full Text] [Related]

  • 46. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.
    Asper M, Sternsdorf T, Hass M, Drosten C, Rhode A, Schmitz H, Günther S.
    J Virol; 2004 Mar 10; 78(6):3162-9. PubMed ID: 14990737
    [Abstract] [Full Text] [Related]

  • 47. Arenavirus reverse genetics for vaccine development.
    Ortiz-Riaño E, Cheng BYH, Carlos de la Torre J, Martínez-Sobrido L.
    J Gen Virol; 2013 Jun 10; 94(Pt 6):1175-1188. PubMed ID: 23364194
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.
    Cheng BYH, Nogales A, de la Torre JC, Martínez-Sobrido L.
    Virology; 2017 Jan 15; 501():35-46. PubMed ID: 27855284
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. An Antiviral Drug Screening Platform with a FRET Biosensor for Measurement of Arenavirus Z Assembly.
    Mizutani T, Ohba Y, Mizuta S, Yasuda J, Urata S.
    Cell Struct Funct; 2020 Dec 25; 45(2):155-163. PubMed ID: 33191384
    [Abstract] [Full Text] [Related]

  • 53. Activation of the STAT3 Signaling Pathway by the RNA-Dependent RNA Polymerase Protein of Arenavirus.
    Wang Q, Xin Q, Shang W, Wan W, Xiao G, Zhang LK.
    Viruses; 2021 May 25; 13(6):. PubMed ID: 34070281
    [Abstract] [Full Text] [Related]

  • 54. Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses.
    Iwasaki M, Minder P, Caì Y, Kuhn JH, Yates JR, Torbett BE, de la Torre JC.
    PLoS Pathog; 2018 Feb 25; 14(2):e1006892. PubMed ID: 29462184
    [Abstract] [Full Text] [Related]

  • 55. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest.
    Emonet SF, Garidou L, McGavern DB, de la Torre JC.
    Proc Natl Acad Sci U S A; 2009 Mar 03; 106(9):3473-8. PubMed ID: 19208813
    [Abstract] [Full Text] [Related]

  • 56. Characterization of non-standard viral genomes during arenavirus infections identifies prominent S RNA intergenic region deletions.
    Hackbart M, López CB.
    mBio; 2024 Oct 16; 15(10):e0161224. PubMed ID: 39258905
    [Abstract] [Full Text] [Related]

  • 57. The Pan-ErbB tyrosine kinase inhibitor afatinib inhibits multiple steps of the mammarenavirus life cycle.
    Mizuma K, Takashima A, Cubitt B, de la Torre JC, Iwasaki M.
    Virology; 2022 Nov 16; 576():83-95. PubMed ID: 36183499
    [Abstract] [Full Text] [Related]

  • 58. Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers.
    Lee AM, Rojek JM, Gundersen A, Ströher U, Juteau JM, Vaillant A, Kunz S.
    Virology; 2008 Mar 01; 372(1):107-17. PubMed ID: 18022208
    [Abstract] [Full Text] [Related]

  • 59. Potent inhibition of arenavirus infection by a novel fusion inhibitor.
    Gowen BB, Naik S, Westover JB, Brown ER, Gantla VR, Fetsko A, Dagley AL, Blotter DJ, Anderson N, McCormack K, Henkel G.
    Antiviral Res; 2021 Sep 01; 193():105125. PubMed ID: 34197863
    [Abstract] [Full Text] [Related]

  • 60. The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production.
    Xing J, Ly H, Liang Y.
    J Virol; 2015 Mar 01; 89(5):2944-55. PubMed ID: 25552708
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.